FDA OKs imported syphilis antibiotic during penicillin shortage

The FDA said this week that it is working with a French pharmaceutical company to temporarily import into the United States an antibiotic that can treat syphilis as a way to address the country’s penicillin shortage.
Last June, Pfizer announced that it was facing a “limited supply and impending stock out” for two of its injectable penicillin products, in part because of a surge in syphilis infections, including an increase in congenital syphilis — 3,761 reported cases in 2022 alone — that the CDC has called a “crisis.”
The two products are Bicillin C-R

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart